Related Experiment Video
Updated: Jun 11, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release
Haining Yang1, Zeyana Rivera, Sandro Jube
1Cancer Research Center of Hawaii, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI 96813, USA. hyang@crch.hawaii.edu
Abstract:
Asbestos carcinogenesis has been linked to the release of cytokines and mutagenic reactive oxygen species (ROS) from inflammatory cells. Asbestos is cytotoxic to human mesothelial cells (HM), which appears counterintuitive for a carcinogen. We show that asbestos-induced HM cell death is a regulated form of necrosis that links to carcinogenesis. Asbestos-exposed HM activate poly(ADP-ribose) polymerase, secrete H(2)O(2), deplete ATP, and translocate high-mobility group box 1 protein (HMGB1) from the nucleus to the cytoplasm, and into the extracellular space. The release of HMGB1 induces macrophages to secrete TNF-alpha, which protects HM from asbestos-induced cell death and triggers a chronic inflammatory response; both favor HM transformation. In both mice and hamsters injected with asbestos, HMGB1 was specifically detected in the nuclei, cytoplasm, and extracellular space of mesothelial and inflammatory cells around asbestos deposits. TNF-alpha was coexpressed in the same areas. HMGB1 levels in asbestos-exposed individuals were significantly higher than in nonexposed controls (P < 0.0001). Our findings identify the release of HMGB1 as a critical initial step in the pathogenesis of asbestos-related disease, and provide mechanistic links between asbestos-induced cell death, chronic inflammation, and carcinogenesis. Chemopreventive approaches aimed at inhibiting the chronic inflammatory response, and especially blocking HMGB1, may decrease the risk of malignant mesothelioma among asbestos-exposed cohorts.
Insights
Asbestos exposure causes human mesothelial cell death, releasing high-mobility group box 1 (HMGB1). This protein triggers inflammation and protects cells, promoting asbestos-related cancer development.
Area of Science:
- Cell Biology
- Toxicology
- Cancer Research
Background:
- Asbestos exposure is linked to cancer via inflammation and reactive oxygen species (ROS).
- Asbestos cytotoxicity to human mesothelial cells (HM) seems paradoxical for a carcinogen.
Purpose of the Study:
- To investigate the mechanism of asbestos-induced cell death in HM and its link to carcinogenesis.
- To identify key molecular events connecting asbestos exposure, inflammation, and cancer development.
Main Methods:
- Examined asbestos-induced cell death in HM, measuring poly(ADP-ribose) polymerase activation, H(2)O(2) secretion, ATP depletion, and high-mobility group box 1 protein (HMGB1) translocation.
- Investigated HMGB1 and TNF-alpha expression in mesothelial and inflammatory cells in animal models exposed to asbestos.
- Assessed HMGB1 levels in individuals exposed to asbestos versus controls.
Main Results:
- Asbestos-induced HM cell death is a regulated necrosis.
- HMGB1 translocates from the nucleus to the extracellular space, inducing macrophages to secrete TNF-alpha.
- TNF-alpha protects HM from cell death but promotes chronic inflammation and transformation.
- Elevated HMGB1 levels were observed in asbestos-exposed individuals.
Conclusions:
- HMGB1 release is a critical initial step in asbestos-related disease pathogenesis.
- Mechanistic links between asbestos-induced cell death, chronic inflammation, and carcinogenesis are established.
- Targeting HMGB1 and the inflammatory response may offer chemopreventive strategies against malignant mesothelioma.
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Induced Pluripotent Stem Cells
Somatic cells are...
Cellular Injury IV: Necrosis
Abnormal Proliferation
Cellular Injury IlI: Cellular Death
Inflammatory Bowel Disease III: Crohn's Disease
